Survey 30 : Montina in patients with cardiac co-morbidities.MCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File 1. How often do you see allergic rhinitis patients with cardiac comorbidities in your practice? Rarely (Less than 10%) Sometimes (10–30%) Frequently (30–60%) Very Often (>60%)2. When prescribing a montelukast-antihistamine combination to a patient with a known cardiac condition, which potential risk is your PRIMARY concern? Arrhythmia or QT interval issues. BP or heart failure effects Drug interactions No major concern3. Which Montelukast–antihistamine combination do you consider safest for cardiac patients? Fexofenadine Levocetirizine Bilastine I do not perceive a significant safety difference between them.4. Does a patient's cardiac history typically lead you to choose a specific antihistamine over others? Yes, always a key factor Sometimes, depends on severity No, other factors matter more I avoid in significant cardiac history5. In your clinical experience, have you observed a cardiovascular adverse event in a patient that you suspected was related to a montelukast-antihistamine combination? Yes, on one or more occasions. I have suspected it, but the link was not definitive. No, I have never observed such an event. I do not typically monitor for these specific adverse events.6. What is your general stance on prescribing these combinations to patients with a history of significant cardiac disease (e.g., heart failure, arrhythmia)? Use with caution, choose carefully Better to avoid, prefer alternatives Risk negligible with modern drugs Depends on patient profile7. How do you monitor cardiac patients on these combinations? ECG before/after starting ECG only if symptoms No specific monitoring Cardiologist manages it8. In a typical week, how many patients do you see who have both a heart condition and allergies? 1 to 5 6 to 10 More than 10 None or very few9. When you prescribe a montelukast-antihistamine combo to a patient with a heart condition, how often do you choose Levocetirizine? Almost always About half the time Rarely I don't have a specific preference10. In the past year, how many patients on these combinations have reported heart-related side effects (like palpitations) to you? None 1 or 2 patients 3 to 5 patients More than 5 patients I have read and agree to the Terms and Conditions .Submit Form